Skip to main content
Erschienen in: Medical Oncology 10/2014

01.10.2014 | Original Paper

Investigation of DNA repair gene variants on myelodysplastic syndromes in a Turkish population

verfasst von: Mehmet Burak Aktuglu, Mesut Ayer, Elif S. Bireller, Cagla Rencuzogullari, Hasan Acik, Zeynep Karaali, Taner Alioglu, Namik Yigit, Mustafa Velet, Eray Atalay, Oznur Sari Ure, Bedia Cakmakoglu

Erschienen in: Medical Oncology | Ausgabe 10/2014

Einloggen, um Zugang zu erhalten

Abstract

The aim of this study was to assess the possible influence of genetic polymorphisms in hOGG1, XRCC1, XRCC3, XPD, XPG and APE1 on the observed DNA damage in a group of Turkish myelodysplastic syndrome (MDS) patients. A total of 39 patients with myelodysplastic syndrome and 78 age-matched healthy control subjects were included in our study. Polymerase chain reaction/restriction fragment length polymorphism analysis was performed for the detection of DNA repair gene variants. No significant differences in DNA repair enzymes APE1, XRCC1 and XPG were found between MDS patients and controls. On the other hand, XRCC3, XPD and hOGG1 were associated with an increased risk of MDS (p = 0.004, p = 0.000, p = 0.017, respectively). Specifically, Thr/Met genotype was more relevant in patients (p = 0.026) in XRCC3; in hOGG1, Cys+ genotype was found higher in patients (p = 0.017); and in XPD, Gln/Gln genotypes were found higher in the patient (p = 0.001). In conclusion, XRCC3, XPD and hOGG1 genotypes are associated with an increased MDS risk, suggesting their possible involvement in the pathogenesis and biology of this disease.
Literatur
1.
Zurück zum Zitat Sterpone S, Cozzi R. Influence of XRCC1 genetic polymorphisms on ionizing radiation-induced DNA damage and repair. J Nucleic Acids. 2010;25:2010. Sterpone S, Cozzi R. Influence of XRCC1 genetic polymorphisms on ionizing radiation-induced DNA damage and repair. J Nucleic Acids. 2010;25:2010.
2.
Zurück zum Zitat Altieri F, Grillo C, Maceroni M, Chichiarelli S. DNA damage and repair: from molecular mechanisms to health implications. Antioxid Redox Signal. 2008;10:891–937.PubMedCrossRef Altieri F, Grillo C, Maceroni M, Chichiarelli S. DNA damage and repair: from molecular mechanisms to health implications. Antioxid Redox Signal. 2008;10:891–937.PubMedCrossRef
3.
Zurück zum Zitat Iarmarcovai G, Bonassi S, Botta A, Baan RA, Orsière T. Genetic polymorphisms and micronucleus formation: a review of the literature. Mutat Res. 2008;658:215–33.PubMedCrossRef Iarmarcovai G, Bonassi S, Botta A, Baan RA, Orsière T. Genetic polymorphisms and micronucleus formation: a review of the literature. Mutat Res. 2008;658:215–33.PubMedCrossRef
4.
Zurück zum Zitat Tanrikulu S, Doğru-Abbasoğlu S, Ozderya A, et al. The 8-oxoguanine DNA N-glycosylase 1 (hOGG1) Ser326Cys variant affects the susceptibility to Graves’ disease. Cell Biochem Funct. 2011;29:244–8.PubMedCrossRef Tanrikulu S, Doğru-Abbasoğlu S, Ozderya A, et al. The 8-oxoguanine DNA N-glycosylase 1 (hOGG1) Ser326Cys variant affects the susceptibility to Graves’ disease. Cell Biochem Funct. 2011;29:244–8.PubMedCrossRef
5.
Zurück zum Zitat Masson JY, Tarsounas MC, Stasiak AZ, et al. Identification and purification of two distinct complexes containing the five RAD51 paralogs. Genes Dev. 2001;15:3296–307.PubMedCrossRefPubMedCentral Masson JY, Tarsounas MC, Stasiak AZ, et al. Identification and purification of two distinct complexes containing the five RAD51 paralogs. Genes Dev. 2001;15:3296–307.PubMedCrossRefPubMedCentral
6.
Zurück zum Zitat Lunn RM, Helzlsouer KJ, Parshad R, et al. XPD polymorphisms: effects on DNA repair proficiency. Carcinogenesis. 2000;21:551–5.PubMedCrossRef Lunn RM, Helzlsouer KJ, Parshad R, et al. XPD polymorphisms: effects on DNA repair proficiency. Carcinogenesis. 2000;21:551–5.PubMedCrossRef
7.
Zurück zum Zitat Friedberg EC, Bond JP, Burns DK, et al. Defective nucleotide excision repair in xpc mutant mice and its association with cancer predisposition. Mutat Res. 2000;459:99–108.PubMedCrossRef Friedberg EC, Bond JP, Burns DK, et al. Defective nucleotide excision repair in xpc mutant mice and its association with cancer predisposition. Mutat Res. 2000;459:99–108.PubMedCrossRef
8.
9.
Zurück zum Zitat Willman CL. Molecular genetic features of myelodysplastic syndromes (MDS). Leukemia. 1998;12:S2–6.PubMed Willman CL. Molecular genetic features of myelodysplastic syndromes (MDS). Leukemia. 1998;12:S2–6.PubMed
10.
Zurück zum Zitat Shin A, Lee KM, Ahn B, et al. Genotype-phenotype relationship between DNA repair gene genetic polymorphisms and DNA repair capacity. Asian Pac J Cancer Prev. 2008;9:501–5.PubMed Shin A, Lee KM, Ahn B, et al. Genotype-phenotype relationship between DNA repair gene genetic polymorphisms and DNA repair capacity. Asian Pac J Cancer Prev. 2008;9:501–5.PubMed
11.
Zurück zum Zitat Fabiani E, D’Alò F, Scardocci A, et al. Polymorphisms of detoxification and DNA repair enzymes in myelodysplastic syndromes. Leuk Res. 2009;33:1068–71.PubMedCrossRef Fabiani E, D’Alò F, Scardocci A, et al. Polymorphisms of detoxification and DNA repair enzymes in myelodysplastic syndromes. Leuk Res. 2009;33:1068–71.PubMedCrossRef
12.
13.
Zurück zum Zitat Warlick ED, Smith BD. Myelodysplastic syndromes: review of pathophysiology and current novel treatment approaches. Curr Cancer Drug Targets. 2007;7:541–58.PubMedCrossRef Warlick ED, Smith BD. Myelodysplastic syndromes: review of pathophysiology and current novel treatment approaches. Curr Cancer Drug Targets. 2007;7:541–58.PubMedCrossRef
14.
Zurück zum Zitat Chen H, Sandler DP, Taylor JA, et al. Increased risk for myelodysplastic syndromes in individuals with glutathione transferase theta 1 (GSTT1) gene defect. Lancet. 1996;347:295–7.PubMedCrossRef Chen H, Sandler DP, Taylor JA, et al. Increased risk for myelodysplastic syndromes in individuals with glutathione transferase theta 1 (GSTT1) gene defect. Lancet. 1996;347:295–7.PubMedCrossRef
15.
Zurück zum Zitat Sasai Y, Horiike S, Misawa S, et al. Genotype of glutathione S-transferase and other genetic configurations in myelodysplasia. Leuk Res. 1999;23:975–81.PubMedCrossRef Sasai Y, Horiike S, Misawa S, et al. Genotype of glutathione S-transferase and other genetic configurations in myelodysplasia. Leuk Res. 1999;23:975–81.PubMedCrossRef
16.
Zurück zum Zitat Tsabouri SE, Georgiou I, Alamanos I, Bourantas KL. Increased prevalence of GSTM(1) null genotype in patients with myelodysplastic syndrome: a case–control study. Acta Haematol. 2000;104:169–73.PubMedCrossRef Tsabouri SE, Georgiou I, Alamanos I, Bourantas KL. Increased prevalence of GSTM(1) null genotype in patients with myelodysplastic syndrome: a case–control study. Acta Haematol. 2000;104:169–73.PubMedCrossRef
17.
Zurück zum Zitat Broberg K, Höglund M, Gustafsson C, et al. Genetic variant of the human homologous recombination-associated gene RMI1 (S455N) impacts the risk of AML/MDS and malignant melanoma. Cancer Lett. 2007;258:38–44.PubMedCrossRef Broberg K, Höglund M, Gustafsson C, et al. Genetic variant of the human homologous recombination-associated gene RMI1 (S455N) impacts the risk of AML/MDS and malignant melanoma. Cancer Lett. 2007;258:38–44.PubMedCrossRef
18.
Zurück zum Zitat Belickova M, Merkerova MD, Stara E, et al. DNA repair gene variants are associated with an increased risk of myelodysplastic syndromes in a Czech population. J Hematol Oncol. 2013;6:9.PubMedCrossRefPubMedCentral Belickova M, Merkerova MD, Stara E, et al. DNA repair gene variants are associated with an increased risk of myelodysplastic syndromes in a Czech population. J Hematol Oncol. 2013;6:9.PubMedCrossRefPubMedCentral
19.
Zurück zum Zitat Allan JM, Smith AG, Wheatley K, et al. Genetic variation in XPD predicts treatment outcome and risk of acute myeloid leukemia following chemotherapy. Blood. 2004;104:3872–7.PubMedCrossRef Allan JM, Smith AG, Wheatley K, et al. Genetic variation in XPD predicts treatment outcome and risk of acute myeloid leukemia following chemotherapy. Blood. 2004;104:3872–7.PubMedCrossRef
20.
Zurück zum Zitat Voso MT, Hohaus S, Guidi F, et al. Prognostic role of glutathione S-transferase polymorphisms in acute myeloid leukemia. Leukemia. 2008;22:1685–91.PubMedCrossRef Voso MT, Hohaus S, Guidi F, et al. Prognostic role of glutathione S-transferase polymorphisms in acute myeloid leukemia. Leukemia. 2008;22:1685–91.PubMedCrossRef
21.
Zurück zum Zitat Voso MT, D’Alo’ F, Putzulu R, et al. Negative prognostic value of glutathione S-transferase (GSTM1 and GSTT1) deletions in adult acute myeloid leukemia. Blood. 2002;100:2703–7.PubMedCrossRef Voso MT, D’Alo’ F, Putzulu R, et al. Negative prognostic value of glutathione S-transferase (GSTM1 and GSTT1) deletions in adult acute myeloid leukemia. Blood. 2002;100:2703–7.PubMedCrossRef
22.
Zurück zum Zitat Griffin CS, Simpson PJ, Wilson CR, Thacker J. Mammalian recombination-repair genes XRCC2 and XRCC3 promote correct chromosome segregation. Nat Cell Biol. 2000;2:757–61.PubMedCrossRef Griffin CS, Simpson PJ, Wilson CR, Thacker J. Mammalian recombination-repair genes XRCC2 and XRCC3 promote correct chromosome segregation. Nat Cell Biol. 2000;2:757–61.PubMedCrossRef
23.
Zurück zum Zitat Cui X, Brenneman M, Meyne J, Oshimura M, Goodwin EH, Chen DJ. The XRCC2 and XRCC3 repair genes are required for chromosome stability in mammalian cells. Mutat Res. 1999;434:75–88.PubMedCrossRef Cui X, Brenneman M, Meyne J, Oshimura M, Goodwin EH, Chen DJ. The XRCC2 and XRCC3 repair genes are required for chromosome stability in mammalian cells. Mutat Res. 1999;434:75–88.PubMedCrossRef
24.
Zurück zum Zitat Matullo G, Palli D, Peluso M, et al. XRCC1, XRCC3, XPD gene polymorphisms, smoking and (32)P-DNA adducts in a sample of healthy subjects. Carcinogenesis. 2001;22:1437–45.PubMedCrossRef Matullo G, Palli D, Peluso M, et al. XRCC1, XRCC3, XPD gene polymorphisms, smoking and (32)P-DNA adducts in a sample of healthy subjects. Carcinogenesis. 2001;22:1437–45.PubMedCrossRef
25.
Zurück zum Zitat Costa RM, Chiganças V, Galhardo Rda S, Carvalho H, Menck CF. The eukaryotic nucleotide excision repair pathway. Biochimie. 2003;85:1083–99.PubMedCrossRef Costa RM, Chiganças V, Galhardo Rda S, Carvalho H, Menck CF. The eukaryotic nucleotide excision repair pathway. Biochimie. 2003;85:1083–99.PubMedCrossRef
26.
Zurück zum Zitat Coppedè F, Mancuso M, Lo Gerfo A, et al. A Ser326Cys polymorphism in the DNA repair gene hOGG1 is not associated with sporadic Alzheimer’s disease. Neurosci Lett. 2007;414:282–5.PubMedCrossRef Coppedè F, Mancuso M, Lo Gerfo A, et al. A Ser326Cys polymorphism in the DNA repair gene hOGG1 is not associated with sporadic Alzheimer’s disease. Neurosci Lett. 2007;414:282–5.PubMedCrossRef
Metadaten
Titel
Investigation of DNA repair gene variants on myelodysplastic syndromes in a Turkish population
verfasst von
Mehmet Burak Aktuglu
Mesut Ayer
Elif S. Bireller
Cagla Rencuzogullari
Hasan Acik
Zeynep Karaali
Taner Alioglu
Namik Yigit
Mustafa Velet
Eray Atalay
Oznur Sari Ure
Bedia Cakmakoglu
Publikationsdatum
01.10.2014
Verlag
Springer US
Erschienen in
Medical Oncology / Ausgabe 10/2014
Print ISSN: 1357-0560
Elektronische ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-014-0174-6

Weitere Artikel der Ausgabe 10/2014

Medical Oncology 10/2014 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.